Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Item No. 31612

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
4-Methylaminoantipyrine is a major active metabolite of the non-opioid prodrug metamizole (Item No. 15771).1 It is formed from metamizole by non-enzymatic hydrolysis in the gastrointestinal tract.2 4-Methylaminoantipyrine (0.1 mM) inhibits production of prostaglandin E2 (PGE2; Item No. 14010) induced by the calcium ionophore A23187 (Item Nos. 11016 | 22030) in isolated mouse peritoneal macrophages.3 It increases the paw withdrawal threshold in a rat model of carrageenan-induced hyperalgesia when administered at a dose of 160 µg/paw.4 4-Methylaminoantipyrine (60, 90, and 120 mg/kg) reduces LPS-induced pyrexia in rats.5 It is also a potential impurity found in commercial preparations of metamizole.6
WARNING This product is not for human or veterinary use.
1. Novel bioactive metabolites of dipyrone (metamizol). Bioorg. Med. Chem. 20(1), 101-107 (2012).
2. Metamizole: A review profile of a well-
3. Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages. Agents Actions 14(5-6), 729-734 (1984).
4. Dipyrone is locally hydrolyzed to 4-
5. Dipyrone metabolite 4-
6. HPLC–DAD method for simultaneous determination of dipyrone (metamizole) and caffeine in tablets and identification of major degradation product by direct infusion ESI–MS. Chromatographia 80(3), 489–495 (2017).